第 1 到 298 筆結果,共 298 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2020 | Effects and safety of body positioning on back pain after transcatheter arterial chemoembolization in people with hepatocellular carcinoma: A randomized controlled study | Chang, Kai-Ting; CHUN-JEN LIU ; Tsai, Hsiu-Ting; Hsu, Tse-Pin; PO-TING CHEN ; Hu, Sophia H | International journal of nursing studies | 2 | 3 | |
2 | 2020 | Hepatitis C and hepatitis B coinfection | CHUN-JEN LIU ; JIA-HORNG KAO | Clinical Dilemmas in Viral Liver Disease, Second Edition | |||
3 | 2020 | Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy | TAI-CHUNG TSENG ; Peng C.-Y; Hsu Y.-C; TUNG-HUNG SU ; Wang C.-C; CHUN-JEN LIU ; HUNG-CHIH YANG ; Yang W.-T; Lin C.-H; Yu M.-L; Lai H.-C; Tanaka Y; Nguyen M.H; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Liver Cancer | 17 | 13 | |
4 | 2020 | Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan | Su H.-J.; JIA-HORNG KAO ; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; TUNG-HUNG SU ; PEI-JER CHEN ; CHUN-JEN LIU | Journal of the Formosan Medical Association | 17 | 12 | |
5 | 2020 | Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment | CHEN-HUA LIU ; Yang S.-S.; Peng C.-Y.; Lin W.-T.; CHUN-JEN LIU ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Viral Hepatitis | 20 | 20 | |
6 | 2020 | Limited drug–drug interaction of elbasvir/grazoprevir for chronic hepatitis C | CHUN-JEN LIU ; Tseng K.-C.; Lo C.-C.; Tseng I.-H.; Cheng P.-N. | Journal of the Formosan Medical Association | 3 | 2 | |
7 | 2020 | Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer | TUNG-HUNG SU ; TAI-CHUNG TSENG ; CHUN-JEN LIU ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | International Journal of Cancer | 4 | 4 | |
8 | 2020 | Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis | Hsu W.-F.; Chen C.-Y.; Tseng K.-C.; Lai H.-C.; Kuo H.-T.; Hung C.-H.; Tung S.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Lin C.-Y.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; JIA-HORNG KAO ; CHUN-JEN LIU ; CHEN-HUA LIU ; Yan S.-L.; Bair M.-J.; Su W.-W.; Chu C.-H.; Chen C.-J.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Tsai P.-C.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Yu M.-L.; Peng C.-Y. | Scientific Reports | 4 | 4 | |
9 | 2020 | Twelve weeks of ledipasvir/sofosbuvir all-oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trials | Asahina Y.; CHUN-JEN LIU ; Gane E.; Itoh Y.; Kawada N.; Ueno Y.; Youn J.; Wang C.-Y.; Llewellyn J.; Matsuda T.; Gaggar A.; Mo H.; Dvory-Sobol H.; Crans G.; Chuang W.-L.; PEI-JER CHEN ; Enomoto N. | Hepatology Research | 6 | 6 | |
10 | 2020 | High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy | Chang W.-Y.; Chiu Y.-C; Chiu F.-W; Hsu Y.-C; TAI-CHUNG TSENG ; Cheng P.-N; Yang S.-S; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 5 | 5 | |
11 | 2020 | Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan | CHEN-HUA LIU ; CHUN-JEN LIU ; CHIEN-CHING HUNG ; SZU-MIN HSIEH ; TUNG-HUNG SU ; HSIN-YUN SUN ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Liver International | 21 | 20 | |
12 | 2020 | Long-term growth and bone development in children of HBV-infected mothers with and without fetal exposure to tenofovir disoproxil fumarate | Wen W.-H.; HUEY-LING CHEN ; TIFFANY TING-FANG SHIH ; JIA-FENG WU ; YEN-HSUAN NI ; CHIEN-NAN LEE ; Zhao L.-L.; Lai M.-W.; Mu S.-C.; YI-CHING TUNG ; HONG-YUAN HSU ; MEI-HWEI CHANG ; MING-KWANG SHYU ; HSIAO-LIN HWA ; Su Y.N.; JIN-CHUNG SHIH ; KUANG-HAN CHAO ; YU-CHUN CHIU ; KAI-CHI CHANG ; CHUN-JEN LIU ; TUNG-HUNG SU ; DING-SHINN CHEN ; Chen S.M.; Lin C.C.; Lin P.Y.; Yang W.R.; Hu J.J.; Yang C.K.; Chang Y.K.; Chen K.H.; Lin H.H.; Lin Y.H.; Chen H.J.; Pan H.S.; Lau B.H.; Lee C.L.; Cheng P.J.; Chang Y.L.; Chiueh H.Y.; Wang T.H.; Hsu J.J.; Lo L.M.; Hsieh C.L.; Cheng S.W.; Tsai M.S.; Lin L.H.; She B.Q.; Peng F.S.; Lin Y.C.; Chen C.P.; Huang J.P.; Yeung C.Y.; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study) | Journal of Hepatology | 23 | 21 | |
13 | 2020 | Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing | Yang Y.-C.; Chen Y.-H; JIA-HORNG KAO ; Ching C; Liu I.-J; Wang C.-C; Tsai C.-H; Wu F.-Y; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; HUNG-CHIH YANG | Molecular Therapy - Nucleic Acids | 59 | 52 | |
14 | 2020 | 2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population | Yu M.-L.; PEI-JER CHEN ; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; CHEN-HUA LIU ; CHUN-JEN LIU ; Peng C.-Y.; Lin H.-C.; JIA-HORNG KAO ; Chuang W.-L. | Journal of the Formosan Medical Association | 57 | 51 | |
15 | 2020 | Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis | TUNG-HUNG SU ; Peng C.-Y; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; CHUN-JEN LIU ; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 10 | 8 | |
16 | 2020 | Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis | CHEN-HUA LIU ; Peng C.-Y.; YU-JEN FANG ; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; TUNG-HUNG SU ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Scientific Reports | 8 | 6 | |
17 | 2020 | Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals | CHEN-HUA LIU ; Lee M.-H.; JOU-WEI LIN ; CHUN-JEN LIU ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Hepatology | 41 | 43 | |
18 | 2020 | Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH) | Huang C.-F.; Lai H.-C.; Chen C.-Y.; Tseng K.-C.; Kuo H.-T.; Hung C.-H.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; JIA-HORNG KAO ; CHUN-JEN LIU ; CHEN-HUA LIU ; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Tsai P.-C.; Peng C.-Y.; Yu M.-L. | The American journal of gastroenterology | 20 | 17 | |
19 | 2020 | Longitudinal change of metabolite profile and its relation to multiple risk factors for the risk of developing hepatitis B-related hepatocellular carcinoma | Huang B.-Y.; Tsai M.-R.; Hsu J.-K.; CHING-YU LIN ; Lin C.-L.; Hu J.-T.; Huang Y.-W.; CHUN-JEN LIU ; Wu W.-J.; Wu C.-F.; Sung F.-Y.; PEI-JER CHEN ; Liang H.-J.; Lin S.-M.; MING-WHEI YU | Molecular Carcinogenesis | 9 | 6 | |
20 | 2020 | Hepatitis C virus and hepatitis B virus co-infection | Shih Y.-F.; CHUN-JEN LIU | Viruses | 24 | 22 | |
21 | 2020 | Elimination of hepatitis B in highly endemic settings: Lessons learned in Taiwan and challenges ahead | CHUN-JEN LIU ; PEI-JER CHEN | Viruses | 25 | 19 | |
22 | 2020 | Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment | CHEN-HUA LIU ; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; CHUN-JEN LIU ; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; YU-JEN FANG ; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; JIA-HORNG KAO | Gut | 26 | 27 | |
23 | 2020 | 2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations | Yu M.-L.; PEI-JER CHEN ; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; CHEN-HUA LIU ; CHUN-JEN LIU ; Peng C.-Y.; Lin H.-C.; JIA-HORNG KAO ; Chuang W.-L. | Journal of the Formosan Medical Association | 57 | 47 | |
24 | 2020 | Successful antiviral therapy reduces risk of schizophrenia among chronic hepatitis c patients: A nationwide real-world Taiwanese cohort (T-COACH) | Tsai P.-C.; Chen C.-Y.; Kuo H.-T.; Hung C.-H.; Tseng K.-C.; Lai H.-C.; Peng C.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; JIA-HORNG KAO ; CHUN-JEN LIU ; CHEN-HUA LIU ; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Tai C.-M.; Lin C.-W.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang C.-F.; Hsieh M.-H.; Huang J.-F.; Dai C.-Y.; Chung W.-L.; Ke C.-L.K.; Yu M.-L.; T-COACH Study Group | Open Forum Infectious Diseases | 3 | 3 | |
25 | 2020 | Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection | Cheng X.; Uchida T.; Xia Y.; Umarova R.; CHUN-JEN LIU ; PEI-JER CHEN ; Gaggar A.; Suri V.; Mücke M.M.; Vermehren J.; Zeuzem S.; Teraoka Y.; Osawa M.; Aikata H.; Tsuji K.; Mori N.; Hige S.; Karino Y.; Imamura M.; Chayama K.; Liang T.J. | Journal of Clinical Investigation | 40 | 36 | |
26 | 2020 | HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis | TAI-CHUNG TSENG ; CHUN-JEN LIU ; Chang C.T; TUNG-HUNG SU ; Yang W.-T; Tsai C.-H; CHI-LING CHEN ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Hepatology | 41 | 32 | |
27 | 2020 | Relationship between serum gamma-glutamyl transferase level and colorectal adenoma | TZU-CHAN HONG ; HUNG-CHIH YANG ; CHI-LING CHEN ; JIA-HORNG KAO ; CHUN-JEN LIU ; Chen M.-J; Wang H.-Y; Kuo Y.-C; Yu L.-Y; Hu K.-C. | PLoS ONE | 4 | 2 | |
28 | 2020 | Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data | CHUN-MING HONG ; CHEN-HUA LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; Chen Y.-W; JIA-HORNG KAO ; CHUN-JEN LIU | Journal of Microbiology, Immunology and Infection | 17 | 18 | |
29 | 2020 | Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in Taiwan | CHEN-HUA LIU ; TUNG-HUNG SU ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 4 | 4 | |
30 | 2019 | Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism | TUNG-HUNG SU ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; Chou S.-W; CHIN-HSIEN LIN ; CHEN-HUA LIU ; CHUN-JEN LIU ; CHI-LING CHEN ; JIA-HORNG KAO | Movement Disorders | 14 | 14 | |
31 | 2019 | A simple non-invasive test for ruling out cirrhosis in chronic hepatitis B | TAI-CHUNG TSENG ; Shih Y.-F.; CHUN-JEN LIU | The Lancet Gastroenterology and Hepatology | 0 | 0 | |
32 | 2019 | Smoking and Hepatitis B Virus–Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine Aminotransferase | Wang Y.-H.; YA-HUI CHUANG ; Wu C.-F.; Jan M.-C.; Wu W.-J.; Lin C.-L.; CHUN-JEN LIU ; YA-CHIEN YANG ; PEI-JER CHEN ; Lin S.-M.; MONG-HSUN TSAI ; Huang Y.-W.; MING-WHEI YU | Hepatology | 23 | 24 | |
33 | 2019 | Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 29 | 26 | |
34 | 2019 | Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection | CHEN-HUA LIU ; TUNG-HUNG SU ; CHUN-JEN LIU ; CHUN-MING HONG ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 14 | 15 | |
35 | 2019 | Profile and value of FIB-4 in patients with dual chronic hepatitis C and B | CHUN-JEN LIU ; TAI-CHUNG TSENG ; Yang W.-T; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 10 | 9 | |
36 | 2019 | Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis | CHEN-HUA LIU ; Shih Y.-L; Yang S.-S; Lin C.-L; YU-JEN FANG ; Cheng P.-N; Chen C.-Y; Peng C.-Y; Hsieh T.-Y; Chiu Y.-C; TUNG-HUNG SU ; CHUN-JEN LIU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 7 | 7 | |
37 | 2019 | Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers | KAI-CHI CHANG ; MEI-HWEI CHANG ; CHIEN-NAN LEE ; Chang C.-H.; JIA-FENG WU ; YEN-HSUAN NI ; Wen W.-H.; MING-KWANG SHYU ; Lai M.-W.; Chen S.-M.; Hu J.-J.; Lin H.H.; Hsu J.-J.; Mu S.-C.; Lin Y.-C.; CHUN-JEN LIU ; DING-SHINN CHEN ; Lin L.-H.; HUEY-LING CHEN ; HSIAO-LIN HWA ; Su Y.-N.; JIN-CHUNG SHIH ; KUANG-HAN CHAO ; HONG-YUAN HSU ; YU-CHUN CHIU ; TUNG-HUNG SU ; Lin C.-C.; Lin P.-Y.; Yang W.-R.; Zhao L.-L.; Yang C.-K.; Chang Y.-K.; Chen K.-H.; Lin Y.-H.; Chen H.-J.; Pan H.-S.; Lau B.-H.; Lee C.-L.; Cheng P.-J.; Chang Y.-L.; Chiueh H.-Y.; Wang T.-H.; Lo L.-M.; Hsieh C.-L.; Cheng S.-W.; Tsai M.-S.; She B.-Q.; Koh K.-J.; Hung Y.-L.; Lin H.-M.; Peng F.-S.; Wu T.-C.; Chen C.-Y.; Chen C.-P.; Huang J.-P.; Yeung C.-Y.; Lin C.-J.; Chiu W.-T.; Wang D.-S.; Lin W.-T.; Hwang K.-S.; Huang C.-F.; The Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study) | Alimentary Pharmacology and Therapeutics | 19 | 18 | |
38 | 2019 | Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions | Yu M.-L.; Hung C.-H.; Huang Y.-H.; Peng C.-Y.; Lin C.-Y.; Cheng P.-N.; Chien R.-N.; SHIH-JER HSU ; CHEN-HUA LIU ; Huang C.-F.; Su C.-W.; Huang J.-F.; CHUN-JEN LIU ; JIA-HORNG KAO ; Chuang W.-L.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of the Formosan Medical Association | 10 | 8 | |
39 | 2019 | High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load | TAI-CHUNG TSENG ; CHUN-JEN LIU ; Hsu C.-Y; CHUN-MING HONG ; TUNG-HUNG SU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; Huang Y.-T; Fang-Tzu Kuo S; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Gastroenterology | 94 | 76 | |
40 | 2019 | NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging | TUNG-HUNG SU ; SIH-HAN LIAO ; CHUN-MING HONG ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; Adhoute X; Bourlière M; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 3 | 3 | |
41 | 2019 | Helicobacter pylori infection combined with non-alcoholic fatty liver disease increase the risk of atherosclerosis: Focus in carotid artery plaque | Yu L.-Y.; Hu K.-C.; CHUN-JEN LIU ; Hung C.-L.; Bair M.-J.; Chen M.-J.; Wang H.-Y.; MING-SHIANG WU ; Shih S.-C.; Liu C.-C. | Medicine | 12 | 12 | |
42 | 2019 | Taiwan consensus statement on the management of chronic hepatitis B | Chien R.-N.; JIA-HORNG KAO ; Peng C.-Y.; Chen C.-H.; CHUN-JEN LIU ; Huang Y.-H.; Hu T.-H.; Yang H.-I.; Lu S.-N.; YEN-HSUAN NI ; Chuang W.-L.; Lee C.-M.; Wu J.-C.; PEI-JER CHEN ; Liaw Y.-F. | Journal of the Formosan Medical Association | 50 | 47 | |
43 | 2019 | Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 10 | 9 | |
44 | 2019 | Decreased Colorectal Adenoma Risk after Helicobacter pylori Eradication: A Retrospective Cohort Study | Hu K.-C.; MING-SHIANG WU ; Chu C.-H.; Wang H.-Y.; Lin S.-C.; Liu C.-C.; TUNG-HUNG SU ; WEI-CHIH LIAO ; CHI-LING CHEN ; CHUN-JEN LIU ; Shih S.-C. | Clinical Infectious Diseases | 15 | 14 | |
45 | 2019 | Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus–Associated Hepatocellular Carcinoma | Li Y.-T.; Wu H.-L.; JIA-HORNG KAO ; Cheng H.-R.; MING-CHIH HO ; Wang C.-C.; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU | Hepatology | 7 | 7 | |
46 | 2018 | Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection | TAI-CHUNG TSENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 18 | 18 | |
47 | 2018 | Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan | CHEN-HUA LIU ; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 25 | 24 | |
48 | 2018 | Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection | CHEN-HUA LIU ; YIH-SHARNG CHEN ; SHOEI-SHEN WANG ; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Clinical Infectious Diseases | 26 | 21 | |
49 | 2018 | Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B | Papatheodoridis G.V.; Manolakopoulos S; TUNG-HUNG SU ; Siakavellas S; CHUN-JEN LIU ; Kourikou A; HUNG-CHIH YANG ; JIA-HORNG KAO | Hepatology | 45 | 39 | |
50 | 2018 | Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection | CHEN-HUA LIU ; HSIN-YUN SUN ; CHUN-JEN LIU ; WANG-HUEI SHENG ; SZU-MIN HSIEH ; Lo Y.-C; Liu W.-C; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 25 | 21 | |
51 | 2018 | Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study | CHEN-HUA LIU ; Huang Y.-J; Yang S.-S; Chang C.-H; Yang S.-S; HSIN-YUN SUN ; CHUN-JEN LIU ; Liu W.-C; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO | Scientific Reports | 25 | 23 | |
52 | 2018 | Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV | CHUN-JEN LIU ; Chuang W.-L.; Sheen I.-S.; Wang H.-Y.; Chen C.-Y.; Tseng K.-C.; Chang T.-T.; Massetto B.; Yang J.C.; Yun C.; Knox S.J.; Osinusi A.; Camus G.; Jiang D.; Brainard D.M.; McHutchison J.G.; Hu T.-H.; Hsu Y.-C.; Lo G.-H.; Chu C.-J.; Chen J.-J.; Peng C.-Y.; Chien R.-N.; PEI-JER CHEN | Gastroenterology | 95 | 82 | |
53 | 2018 | Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan | Hsieh M.-H.; Yeh M.-L.; TUNG-HUNG SU ; Liu T.-W.; Huang C.-F.; Huang C.-I.; Wang S.-C.; Huang J.-F.; Dai C.-Y.; JIA-HORNG KAO ; Chuang W.-L.; PEI-JER CHEN ; CHUN-JEN LIU ; Yu M.-L. | Journal of the Formosan Medical Association | 5 | 4 | |
54 | 2018 | The Asia–Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017—Part 2: Management and special groups | Chitturi S.; Wong V.W.-S.; Chan W.-K.; Wong G.L.-H.; Wong S.K.-H.; Sollano J.; YEN-HSUAN NI ; CHUN-JEN LIU ; Lin Y.-C.; Lesmana L.A.; Kim S.U.; Hashimoto E.; Hamaguchi M.; Goh K.-L.; Fan J.; Duseja A.; Dan Y.Y.; Chawla Y.; Farrell G.; Chan H.L.-Y. | Journal of Gastroenterology and Hepatology (Australia) | 118 | 97 | |
55 | 2018 | A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patients | CHEN-HUA LIU ; CHUN-JEN LIU ; CHUN-MING HONG ; TUNG-HUNG SU ; HUNG-CHIH YANG ; Chen K.-M; Huang Y.-P; Yeh Y.-M; Tien H.-L; Liu Y.-C; JIA-HORNG KAO ; DING-SHINN CHEN ; PEI-JER CHEN | Journal of Gastroenterology and Hepatology (Australia) | 15 | 15 | |
56 | 2018 | Asia–Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017—Part 1: Definition, risk factors and assessment | Wong V.W.-S.; Chan W.-K.; Chitturi S.; Chawla Y.; Dan Y.Y.; Duseja A.; Fan J.; Goh K.-L.; Hamaguchi M.; Hashimoto E.; Kim S.U.; Lesmana L.A.; Lin Y.-C.; CHUN-JEN LIU ; YEN-HSUAN NI ; Sollano J.; Wong S.K.-H.; Wong G.L.-H.; Chan H.L.-Y.; Farrell G. | Journal of Gastroenterology and Hepatology (Australia) | 335 | 303 | |
57 | 2018 | Age and gender may be the key points in hyperglycemic patients with Helicobacter pylori infection combined colorectal adenoma | Kuo Y.-C.; Shih S.-C.; Yu L.-Y.; MING-SHIANG WU ; TUNG-HUNG SU ; CHUN-JEN LIU ; Hu K.-C. | Helicobacter | 1 | 0 | |
58 | 2018 | Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan | CHEN-HUA LIU ; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | PLoS ONE | 11 | 10 | |
59 | 2018 | Acoustic radiation force impulse US imaging: Liver stiffness in patients with chronic hepatitis B with and without antiviral therapy | TUNG-HUNG SU ; Liao C.-H; CHEN-HUA LIU ; KAI-WEN HUANG ; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Radiology | 17 | 14 | |
60 | 2018 | Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy | TUNG-HUNG SU ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; JYH-MING LIOU ; CHEN-HUA LIU ; CHI-LING CHEN ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU ; JIA-HORNG KAO | Journal of Infectious Diseases | 57 | 52 | |
61 | 2017 | Hyperglycemia combined Helicobacter pylori infection increases risk of synchronous colorectal adenoma and carotid artery plaque | Hu K.-C.; MING-SHIANG WU ; Chu C.-H.; Wang H.-Y.; Lin S.-C.; Po H.L.; Bair M.-J.; Liu C.-C.; TUNG-HUNG SU ; CHI-LING CHEN ; CHUN-JEN LIU ; Shih S.-C. | Oncotarget | 17 | 15 | |
62 | 2017 | Mother-to-infant transmission of hepatitis B virus: challenges and perspectives | Shih Y.-F.; CHUN-JEN LIU | Hepatology International | 16 | 17 | |
63 | 2017 | Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers | Kao W.-Y.; Yang S.-H.; Liu W.-J.; Yeh M.-Y.; Lin C.-L.; CHUN-JEN LIU ; Huang C.-J.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN ; MING-WHEI YU | Molecular Carcinogenesis | 20 | 16 | |
64 | 2017 | Synergistic effect of hyperglycemia and Helicobacter pylori infection status on colorectal adenoma risk | Hu K.-C.; MING-SHIANG WU ; Chu C.-H.; Wang H.-Y.; Lin S.-C.; Liu S.-C.; Liu C.-C.; TUNG-HUNG SU ; CHI-LING CHEN ; CHUN-JEN LIU ; Shih S.-C. | Journal of Clinical Endocrinology and Metabolism | 18 | 16 | |
65 | 2017 | Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study | MING-WHEI YU ; Lin C.-L.; CHUN-JEN LIU ; Yang S.-H.; Tseng Y.-L.; Wu C.-F. | Gastroenterology | 129 | 117 | |
66 | 2017 | Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved response | CHUN-MING HONG ; CHUN-JEN LIU ; Shiou-Hwei Yeh ; PEI-JER CHEN | Journal of the Formosan Medical Association | 4 | 3 | |
67 | 2017 | Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up | Chen H.-Y.; TUNG-HUNG SU ; TAI-CHUNG TSENG ; Yang W.-T.; Chen T.-C.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO ; CHUN-JEN LIU | Journal of the Formosan Medical Association | 12 | 9 | |
68 | 2017 | Viral Factors Affecting the Clinical Outcomes of Chronic Hepatitis B | HUNG-CHIH YANG ; Shih Y.-F; CHUN-JEN LIU | Journal of Infectious Diseases | 7 | 7 | |
69 | 2017 | NOhep: Toward Global Control of Hepatitis B Virus Infection - An Introduction | CHUN-JEN LIU ; JIA-HORNG KAO | Journal of Infectious Diseases | 4 | 4 | |
70 | 2017 | Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection | CHEN-HUA LIU ; CHUN-JEN LIU ; TUNG-HUNG SU ; YU-JEN FANG ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Open Forum Infectious Diseases | 42 | 39 | |
71 | 2017 | Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma | TAI-CHUNG TSENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | American Journal of Gastroenterology | 42 | 39 | |
72 | 2017 | Combination therapy for chronic hepatitis B: Current updates and perspectives | TUNG-HUNG SU ; CHUN-JEN LIU | Gut and Liver | 19 | 15 | |
73 | 2017 | Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients | Lee M.-H.; Huang C.-F; Lai H.-C; Lin C.-Y; Dai C.-Y; CHUN-JEN LIU ; Wang J.-H; Huang J.-F; Su W.-P; HUNG-CHIH YANG ; Kee K.-M; Yeh M.-L; Chuang P.-H; SHIH-JER HSU ; Huang C.-I; JIA-HORNG KAO ; CHIEH-CHANG CHEN ; Chen S.-H; Jeng W.-J; Yang H.-I; Yuan Y; Lu S.-N; Sheen I.-S; CHEN-HUA LIU ; Peng C.-Y; Yu M.-L; Chuang W.-L; Chen C.-J. | Scientific Reports | 16 | 14 | |
74 | 2017 | Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis | TUNG-HUNG SU ; Shiau C.-W; Jao P; Yang N.-J; Tai W.-T; CHUN-JEN LIU ; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; CHEN-HUA LIU ; KAI-WEN HUANG ; Hu T.-C; Huang Y.-J; YAO-MING WU ; Chen L.-J; PEI-JER CHEN ; DING-SHINN CHEN ; Chen K.-F; JIA-HORNG KAO | Scientific Reports | 12 | 11 | |
75 | 2016 | Progressive accumulation of mutations in the hepatitis B virus genome and its impact on time to diagnosis of hepatocellular carcinoma | Sung F.-Y.; Lan C.-Y.; Huang C.-J.; Lin C.-L.; CHUN-JEN LIU ; PEI-JER CHEN ; Lin S.-M.; MING-WHEI YU | Hepatology | 14 | 13 | |
76 | 2016 | Associated factors and clinical implications of serum aminotransferase elevation in scrub typhus | TUNG-HUNG SU ; CHUN-JEN LIU ; Shu P.-Y.; Fu Y.-H.; Chang C.-H.; Jao P.; JIA-HORNG KAO | Journal of Microbiology, Immunology and Infection | 6 | 4 | |
77 | 2016 | Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infection | Yang W.-T.; Wu L.-W; TAI-CHUNG TSENG ; CHI-LING CHEN ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU ; JIA-HORNG KAO | Medicine (United States) | 20 | 15 | |
78 | 2016 | Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model | Li Y.-T.; CHUN-JEN LIU ; TUNG-HUNG SU ; Cheng H.-R.; YUNG-MING JENG ; Lin H.-L.; Wang C.-C.; JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN ; Wu H.-L. | Oncotarget | 4 | 4 | |
79 | 2016 | Perspectives on dual hepatitis B and C infection in Taiwan | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; TAI-CHUNG TSENG ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 13 | 12 | |
80 | 2016 | Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis C | Mah Y.-H.; CHEN-HUA LIU ; CHI-LING CHEN ; TAI-CHUNG TSENG ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 6 | 7 | |
81 | 2016 | Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update | Sarin S.K.; Kumar M.; Lau G.K.; Abbas Z.; Chan H.L.Y.; Chen C.J.; DING-SHINN CHEN ; HUEY-LING CHEN ; PEI-JER CHEN ; Chien R.N.; Dokmeci A.K.; Gane E.; Hou J.L.; Jafri W.; Jia J.; Kim J.H.; Lai C.L.; Lee H.C.; Lim S.G.; CHUN-JEN LIU ; Locarnini S.; Al Mahtab M.; Mohamed R.; Omata M.; Park J.; Piratvisuth T.; Sharma B.C.; Sollano J.; Wang F.S.; Wei L.; Yuen M.F.; Zheng S.S.; JIA-HORNG KAO | Hepatology International | 1819 | 1662 | |
82 | 2016 | Asian consensus on the relationship between obesity and gastrointestinal and liver diseases | Koh J.C.; Loo W.M.; Goh K.L.; Sugano K.; Chan W.K.; Chiu W.Y.P.; Choi M.-G.; Gonlachanvit S.; Lee W.-J.; Lee W.J.J.; Lee Y.Y.; Lesmana L.A.; Li Y.-M.; CHUN-JEN LIU ; Matsuura B.; Nakajima A.; Ng E.K.W.; Sollano J.D.; Wong S.K.H.; Wong V.W.S.; Yang Y.; Ho K.Y.; Dan Y.Y. | Journal of Gastroenterology and Hepatology (Australia) | 45 | 39 | |
83 | 2016 | Clinical characteristics and long-term outcome of acute kidney injury in patients with HBV-related acute-on-chronic liver failure | Shi X.; Zhu P.; Yan G.; CHUN-JEN LIU ; Zhang C.; Huang G.; Zhang Y.; Yan Z.; Wang Y. | Journal of Viral Hepatitis | 14 | 13 | |
84 | 2016 | Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer | MEI-HWEI CHANG ; You S.-L.; Chen C.-J.; CHUN-JEN LIU ; Lai M.-W.; Wu T.-C.; Wu S.-F.; Lee C.-M.; Yang S.-S.; Chu H.-C.; Wang T.-E.; Chen B.-W.; Chuang W.-L.; Soon M.-S.; Lin C.-Y.; Chiou S.-T.; Kuo H.-S.; DING-SHINN CHEN ; Yang Y.-J.; Lo G.-H.; Kong M.-S.; Wang P.-M.; Yang C.-C.; Chu C.-H.; Lin L.-H.; Chien R.-N.; Lee T.-H.; Yang K.-C.; Liao L.-Y.; Mo L.-R.; Liu J.-D.; Yang T.-H.; Lo C.-C.; Tsai M.-H.; Chou C.-H.; Cheng Y.-S. | Gastroenterology | 174 | 150 | |
85 | 2016 | Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis | Yang H.-I.; TAI-CHUNG TSENG ; Liu J.; Lee M.-H.; CHUN-JEN LIU ; TUNG-HUNG SU ; Batrla-Utermann R.; Chan H.L.Y.; JIA-HORNG KAO ; Chen C.-J. | Clinical Gastroenterology and Hepatology | 25 | 22 | |
86 | 2016 | Liver gene expression profiles correlate with virus infection and response to interferon therapy in chronic hepatitis B patients | Wu H.-L.; Hsiao T.-H.; PEI-JER CHEN ; Wong S.-H.; JIA-HORNG KAO ; DING-SHINN CHEN ; Lu J.-Y.; TZU-PIN LU ; Chen Y.; Chuang E.Y.; Tu H.-C.; CHUN-JEN LIU ; ERIC YAO-YU CHUANG | Scientific Reports | 23 | 22 | |
87 | 2016 | How Does Aging Affect Presentation and Management of Biliary Stones? | Hu K.-C.; Chu C.-H.; Wang H.-Y.; Chang W.-H.; Lin S.-C.; Liu C.-C.; WEI-CHIH LIAO ; CHUN-JEN LIU ; MING-SHIANG WU ; Shih S.-C. | Journal of the American Geriatrics Society | 9 | 5 | |
88 | 2016 | Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Hepatology | 35 | 31 | |
89 | 2015 | Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Huang, Jee-Fu; JOU-WEI LIN ; Liang, Cheng-Chao; Yang, Sheng-Shun; CHIH-HUNG LIN ; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; JIA-HORNG KAO ; Yu, Ming-Lung | Scientific reports | 8 | 8 | |
90 | 2015 | Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Huang, Jee-Fu; JOU-WEI LIN ; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; JIA-HORNG KAO ; Yu, Ming-Lung | Scientific reports | 7 | 7 | |
91 | 2015 | Rapid prediction of treatment futility of boceprevir with peginterferon-ribavirin for Taiwanese treatment experienced hepatitis C virus genotype 1-infected patients | Yang C.-C.; Tsai W.-L.; Su W.-W.; Huang C.-F.; Cheng P.-N.; Lo C.-C.; Tseng K.-C.; Mo L.-R.; Wang C.-H.; SHIH-JER HSU ; Lai H.-C.; Su C.-W.; CHUN-JEN LIU ; Peng C.-Y.; Yu M.-L. | PLoS ONE | 8 | 5 | |
92 | 2015 | Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: A nation-wide cohort study | YI-WEN HUANG ; Wang T.-C.; Yang S.-S.; Lin S.-Y.; Fu S.-C.; Hu J.-T.; CHUN-JEN LIU ; JIA-HORNG KAO ; DING-SHINN CHEN | Alimentary Pharmacology and Therapeutics | 23 | 23 | |
93 | 2015 | Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers | TAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; CHI-LING CHEN ; Yang W.-T; Tsai C.-S; Kuo S.F.-T; Verbree F.C; TUNG-HUNG SU ; Wang C.-C; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Gut | 98 | 84 | |
94 | 2015 | Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus | HUEY-LING CHEN ; CHIEN-NAN LEE ; Chang C.-H.; YEN-HSUAN NI ; MING-KWANG SHYU ; Chen S.-M.; Hu J.-J.; Lin H.H.; Zhao L.-L.; Mu S.-C.; Lai M.-W.; Lee C.-L.; Lin H.-M.; Tsai M.-S.; Hsu J.-J.; DING-SHINN CHEN ; KIN-WEI CHAN ; MEI-HWEI CHANG ; Su Y.-N.; JIN-CHUNG SHIH ; KUANG-HAN CHAO ; JIA-FENG WU ; HONG-YUAN HSU ; CHUN-JEN LIU ; TUNG-HUNG SU ; Lin C.-C.; Lin P.-Y.; Yang W.-R.; Yang C.-K.; Chang Y.-K.; Chen K.-H.; Lin Y.-H.; Chen H.-J.; Pan H.-S.; Lau B.-H.; Cheng P.-J.; Chang Y.-L.; Chiueh H.-Y.; Wang T.-H.; Lo L.-M.; Hsieh C.-L.; Cheng S.-W.; Lin L.-H.; She B.-Q.; Koh K.-J.; Hung Y.-L.; Peng F.-S.; Lin Y.-C.; Wu T.-C.; Chen C.-Y.; Chen C.-P.; Huang J.-P.; Yeung C.-Y.; Lin C.-J.; Chiu W.-T.; Wang D.-S.; Lin W.-T.; Hwang K.-S.; Huang C.-F.; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT Study) | Hepatology | 216 | 187 | |
95 | 2015 | Serum biomarkers predictive of significant fibrosis and cirrhosis in chronic hepatitis B | Lin C.-L.; CHEN-HUA LIU ; Wang C.-C.; Liang C.-C.; TUNG-HUNG SU ; CHUN-JEN LIU ; JIA-HORNG KAO | Journal of Clinical Gastroenterology | 31 | 32 | |
96 | 2015 | Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection | Cheng H.-R.; JIA-HORNG KAO ; Wu H.-L; TAI-CHUNG TSENG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU | Hepatology International | 14 | 11 | |
97 | 2015 | Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition | TUNG-HUNG SU ; Shiau C.-W; Jao P; CHEN-HUA LIU ; CHUN-JEN LIU ; Tai W.-T; YUNG-MING JENG ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; HSIANG-PO HUANG ; Cheng H.-R; PEI-JER CHEN ; Chen K.-F; JIA-HORNG KAO ; DING-SHINN CHEN | Proceedings of the National Academy of Sciences of the United States of America | 65 | 62 | |
98 | 2015 | Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotyping | CHEN-HUA LIU ; Liang C.-C; CHUN-JEN LIU ; Lin C.-L; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Clinical Microbiology | 58 | 55 | |
99 | 2015 | Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection | TAI-CHUNG TSENG ; CHUN-JEN LIU ; CHI-LING CHEN ; Yang W.-T; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 48 | 43 | |
100 | 2015 | Development of risk scoring system for stratifying population for hepatocellular carcinoma screening | Hung Y.-C.; Lin C.-L.; CHUN-JEN LIU ; Hung Hung ; Lin S.-M.; Lee S.-D.; PEI-JER CHEN ; Chuang S.-C.; MING-WHEI YU | Hepatology | 38 | 39 | |
101 | 2015 | Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study | CHEN-HUA LIU ; WANG-HUEI SHENG ; HSIN-YUN SUN ; SZU-MIN HSIEH ; Lo Y.-C; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; Liu W.-C; PEI-JER CHEN ; DING-SHINN CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO | Scientific Reports | 13 | 12 | |
102 | 2015 | Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial | CHEN-HUA LIU ; CHUN-JEN LIU ; Huang C.-F; JOU-WEI LIN ; Dai C.-Y; Liang C.-C; Huang J.-F; Hung P.-H; Tsai H.-B; MENG-KUN TSAI ; CHIH-YUAN LEE ; Chen S.-I; Yang S.-S; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang W.-L; Yu M.-L; JIA-HORNG KAO | Gut | 36 | 30 | |
103 | 2015 | Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection | Song L.-W.; Liu P.-G; CHUN-JEN LIU ; Zhang T.-Y; Cheng X.-D; Wu H.-L; HUNG-CHIH YANG ; Hao X.-K; Yuan Q; Zhang J; JIA-HORNG KAO ; DING-SHINN CHEN ; PEI-JER CHEN ; Xia N.-S. | Clinical Microbiology and Infection | 98 | 86 | |
104 | 2015 | Micro-evolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: Comparison of genotypes B and C at various immune stages | CHUN-JEN LIU ; Chen T.-C.; PEI-JER CHEN ; HURNG-YI WANG ; TAI-CHUNG TSENG ; Cheng H.-R.; CHEN-HUA LIU ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 1 | 1 | |
105 | 2015 | Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy | Liang C.-C.; CHEN-HUA LIU ; Chung C.-S; Lin C.-K; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 7 | 6 | |
106 | 2014 | The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo | Lin S.-R.; HUNG-CHIH YANG ; Kuo Y.-T; CHUN-JEN LIU ; Yang T.-Y; Sung K.-C; Lin Y.-Y; HURNG-YI WANG ; Wang C.-C; Shen Y.-C; Wu F.-Y; JIA-HORNG KAO ; DING-SHINN CHEN ; PEI-JER CHEN | Molecular Therapy - Nucleic Acids | 325 | 301 | |
107 | 2014 | Association of adjuvant antiviral therapy with risk of cancer progression and deaths in patients with hepatitis-B-virus-related hepatocellular carcinoma following curative treatment: A nationwide cohort study | Yeh Y.-C.; CHUN-JEN LIU ; Kuo R.N.; Lai C.-L.; Shau W.-Y.; PEI-JER CHEN ; Lai M.-S. | PLoS ONE | 13 | 13 | |
108 | 2014 | Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection | CHUN-JEN LIU ; PEI-JER CHEN | World Journal of Gastroenterology | 21 | 19 | |
109 | 2014 | Molecular mechanism and treatment of viral hepatitis-related liver fibrosis | TUNG-HUNG SU ; JIA-HORNG KAO ; CHUN-JEN LIU | International Journal of Molecular Sciences | 57 | 52 | |
110 | 2014 | Identification of a liver cirrhosis signature in plasma for predicting hepatocellular carcinoma risk in a population-based cohort of hepatitis B carriers | Liu C.-C.; Wang Y.-H.; Chuang E.Y.; Tsai M.-H.; YA-HUI CHUANG ; Lin C.-L.; CHUN-JEN LIU ; Hsiao B.-Y.; Lin S.-M.; Liu L.-Y.; MING-WHEI YU | Molecular Carcinogenesis | 7 | 5 | |
111 | 2014 | Circulating programmed death-1 as a marker for sustained high hepatitis b viral load and risk of hepatocellular carcinoma e95870 | Cheng H.-Y.; Kang P.-J.; YA-HUI CHUANG ; Wang Y.-H.; Jan M.-C.; Wu C.-F.; Lin C.-L.; CHUN-JEN LIU ; Liaw Y.-F.; Lin S.-M.; PEI-JER CHEN ; Lee S.-D.; MING-WHEI YU | PLoS ONE | 65 | 25 | |
112 | 2014 | Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality | CHUN-JEN LIU ; Chu, Y.-T.; Shau, W.-Y.; Kuo, R.N.; PEI-JER CHEN ; Lai, M.-S. | Gut | 46 | 39 | |
113 | 2014 | Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously | Cheng H.-R.; JIA-HORNG KAO ; Wu H.-L.; Chen T.-C.; TAI-CHUNG TSENG ; CHEN-HUA LIU ; TUNG-HUNG SU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU | Liver International | 13 | 11 | |
114 | 2014 | Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence | CHUN-JEN LIU ; Chang J.; PO-HUANG LEE ; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; MING-CHIH HO ; Yang S.-S.; Yang M.-D.; Yu M.-C.; REY-HENG HU ; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; PEI-JER CHEN | World Journal of Gastroenterology | 53 | 51 | |
115 | 2014 | Consensus cost-effectiveness model for treatment of chronic hepatitis B in Asia Pacific countries | Dan Y.Y.; Wong J.B.; Hamid S.S.; Han K.-H.; Jia J.D.; CHUN-JEN LIU ; Piratvisuth T.; Lok A.S.F.; Lim S.G. | Hepatology International | 10 | 8 | |
116 | 2014 | Nonalcoholic fatty liver disease: Updates in noninvasive diagnosis and correlation with cardiovascular disease | Hu K.-C.; Wang H.-Y.; Liu S.-C.; Liu C.-C.; Hung C.-L.; Bair M.-J.; CHUN-JEN LIU ; MING-SHIANG WU ; Shih S.-C. | World Journal of Gastroenterology | 25 | 22 | |
117 | 2014 | Clinical presentations of patients from different age cohorts with biliary tract stone diseases | Hu K.-C.; Wang H.-Y.; Chang W.-H.; Chu C.-H.; Lin S.-C.; CHUN-JEN LIU ; MING-SHIANG WU ; Shih S.-C. | Journal of Gastroenterology and Hepatology (Australia) | 10 | 7 | |
118 | 2014 | Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy | TUNG-HUNG SU ; CHUN-JEN LIU ; HUNG-CHIH YANG ; YUNG-MING JENG ; Cheng H.-R; CHEN-HUA LIU ; TAI-CHUNG TSENG ; THAI-YEN LING ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology | 16 | 14 | |
119 | 2014 | Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin | Chen M.-Y.; CHEN-HUA LIU ; Chen T.-C.; TUNG-HUNG SU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO ; CHUN-JEN LIU | Journal of Gastroenterology and Hepatology (Australia) | 8 | 7 | |
120 | 2014 | Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: Resolved and unresolved issues | CHUN-JEN LIU | Journal of Gastroenterology and Hepatology (Australia) | 21 | 17 | |
121 | 2014 | Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications | Wu H.-L.; JIA-HORNG KAO ; Chen T.-C; Wu W.-H; CHEN-HUA LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; DING-SHINN CHEN ; PEI-JER CHEN ; CHUN-JEN LIU | Journal of Gastroenterology and Hepatology (Australia) | 28 | 24 | |
122 | 2014 | Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters | TAI-CHUNG TSENG ; CHUN-JEN LIU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 13 | 9 | |
123 | 2014 | Commentary: Treatment of hepatitis C-related cirrhosis in the era of direct-acting anti-virals | Wong V.W.-S.; CHUN-JEN LIU | Alimentary Pharmacology and Therapeutics | 1 | 1 | |
124 | 2014 | Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: A prospective study in Taiwan | CHI-LING CHEN ; WEI-SHIUNG YANG ; Yang H.-I.; Chen C.-F.; You S.-L.; Wang L.-Y.; Lu S.-N.; CHUN-JEN LIU ; JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN ; Chen C.-J. | Cancer Epidemiology Biomarkers and Prevention | 19 | 16 | |
125 | 2013 | Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; HUNG-BIN TSAI ; MENG-KUN TSAI ; Chen, Shih-I; JOU-WEI LIN ; Yang, Sheng-Shun; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; Yu, Ming-Lung; JIA-HORNG KAO | Annals of internal medicine | 85 | 77 | |
126 | 2013 | Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up | Yu M.-L.; Lee C.-M; CHI-LING CHEN ; Chuang W.-L; Lu S.-N; CHEN-HUA LIU ; Wu S.-S; Liao L.-Y; Kuo H.-T; Chao Y.-C; Tung S.-Y; Yang S.-S; JIA-HORNG KAO ; Su W.-W; Lin C.-L; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU | Hepatology | 65 | 59 | |
127 | 2013 | Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients | Hsu C.-S.; SHIH-JER HSU ; Chen H.-C.; CHEN-HUA LIU ; Jeng J.; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology International | 5 | 5 | |
128 | 2013 | Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers | TAI-CHUNG TSENG ; CHUN-JEN LIU ; CHI-LING CHEN ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Yang W.-T; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 45 | 44 | |
129 | 2013 | Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C | TUNG-HUNG SU ; CHEN-HUA LIU ; CHUN-JEN LIU ; CHI-LING CHEN ; Ting T.-T.; TAI-CHUNG TSENG ; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | Proceedings of the National Academy of Sciences of the United States of America | 53 | 52 | |
130 | 2013 | Treatment options for dual HCV/HBV coinfection | CHUN-JEN LIU ; JIA-HORNG KAO | Emerging Therapeutic Options for Hepatitis C | 0 | 0 | |
131 | 2013 | Hepatitis B virus reactivation in patients receiving cancer chemotherapy: Natural history, pathogenesis, and management | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology International | 43 | 35 | |
132 | 2013 | Host Genetic Factors Affecting Spontaneous HBsAg Seroclearance in Chronic Hepatitis B Patients | Cheng H.-R.; CHUN-JEN LIU ; TAI-CHUNG TSENG ; TUNG-HUNG SU ; Yang H.-I.; Chen C.-J.; JIA-HORNG KAO | PLoS ONE | 48 | 305 | |
133 | 2013 | Impact of Genetic Heterogeneity in Polymerase of Hepatitis B Virus on Dynamics of Viral Load and Hepatitis B Progression | Huang C.-J.; Wu C.-F.; Lan C.-Y.; Sung F.-Y.; Lin C.-L.; CHUN-JEN LIU ; Liu H.-F.; MING-WHEI YU | PLoS ONE | 14 | 15 | |
134 | 2013 | IL-21R gene polymorphisms and serum IL-21 levels predict virological response to interferon-based therapy in Asian chronic hepatitis C patients | Hsu C.-S.; SHIH-JER HSU ; Liu W.-L.; CHI-LING CHEN ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 10 | 8 | |
135 | 2013 | Milder clinical manifestation of scrub typhus in Kinmen, Taiwan | TUNG-HUNG SU ; CHUN-JEN LIU ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 20 | 15 | |
136 | 2013 | Transabdominal ultrasound finding and acute hepatocellular injury in different cohorts of elderly adults with and without common bile duct stones | Hu K.-C.; Wang H.-Y.; Chang W.-H.; Chu C.-H.; Lin S.-C.; CHUN-JEN LIU ; MING-SHIANG WU ; Shih S.-C. | Journal of the American Geriatrics Society | 1 | 1 | |
137 | 2013 | Global perspective on the natural history of chronic hepatitis B: Role of hepatitis B virus genotypes A to J | CHUN-JEN LIU ; JIA-HORNG KAO | Seminars in Liver Disease | 141 | 125 | |
138 | 2013 | Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients | Yuan Q.; Song L.-W.; CHUN-JEN LIU ; Li Z.; Liu P.-G.; Huang C.-H.; Yan Y.; Ge S.-X.; Wang Y.-B.; Peng C.-Y.; Zhang J.; JIA-HORNG KAO ; DING-SHINN CHEN ; PEI-JER CHEN ; Xia N.-S. | Gut | 67 | 63 | |
139 | 2013 | Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; CHI-LING CHEN ; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | PLoS ONE | 21 | 16 | |
140 | 2013 | Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion | HUNG-CHIH YANG ; CHI-LING CHEN ; Shen Y.-C; Peng C.-Y; CHUN-JEN LIU ; TAI-CHUNG TSENG ; TUNG-HUNG SU ; Chuang W.-L; Yu M.-L; Dai C.-Y; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 43 | 37 | |
141 | 2013 | Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads | TAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; CHI-LING CHEN ; Hsu C.-A; Fang-Tzu Kuo S; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 218 | 195 | |
142 | 2013 | Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: A multicentre study | Dai C.-Y.; TAI-CHUNG TSENG ; Wong G.L.H.; Huang J-F.; Wong V.W.S.; CHUN-JEN LIU ; Yu M.-L.; Chuang W.-L.; JIA-HORNG KAO ; Yuen Chan H.L.; DING-SHINN CHEN | Journal of Antimicrobial Chemotherapy | 20 | 19 | |
143 | 2012 | Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy | CHEN-HUA LIU ; Liang C.-C.; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Lin C.-L.; Yang S.-S.; TUNG-HUNG SU ; SHIH-JER HSU ; JOU-WEI LIN ; Chen J.-H.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 40 | 39 | |
144 | 2012 | Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update | Liaw Y.-F.; JIA-HORNG KAO ; Piratvisuth T.; Chan H.L.Y.; Chien R.-N.; CHUN-JEN LIU ; Gane E.; Locarnini S.; Lim S.-G.; Han K.-H.; Amarapurkar D.; Cooksley G.; Jafri W.; Mohamed R.; Hou J.-L.; Chuang W.-L.; Lesmana L.A.; Sollano J.D.; Suh D.-J.; Omata M. | Hepatology International | 835 | 785 | |
145 | 2012 | Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load | TAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; CHI-LING CHEN ; Fang-Tzu Kuo S; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 129 | 115 | |
146 | 2012 | Impact of hepatitis B virus infection on metabolic profiles and modifying factors | Hsu C.-S.; CHEN-HUA LIU ; Wang C.-C.; TAI-CHUNG TSENG ; CHUN-JEN LIU ; CHI-LING CHEN ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Viral Hepatitis | 60 | 54 | |
147 | 2012 | Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B | Pan C.J.-H.; Wu H.-L.; Kuo S.F.-T.; JIA-HORNG KAO ; TAI-CHUNG TSENG ; CHEN-HUA LIU ; PEI-JER CHEN ; CHUN-JEN LIU ; DING-SHINN CHEN | Hepatology International | 17 | 15 | |
148 | 2012 | High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load | TAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; CHI-LING CHEN ; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Gastroenterology | 430 | 381 | |
149 | 2012 | The risky body mass index ranges for significant hepatitis B viral load: A campus-based study | CHIEN-HSIEH CHIANG ; Lai J.-S.; JIN-CHUAN SHEU ; Yen L.-L.; CHUN-JEN LIU ; KUO-CHIN HUANG | Obesity Research and Clinical Practice | 13 | 13 | |
150 | 2012 | Treatment of hepatitis C virus infection: Past, present and future | CHUN-JEN LIU ; DING-SHINN CHEN | Chronic Hepatitis B and C: Basic Science to Clinical Applications | 0 | 0 | |
151 | 2012 | Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin | CHEN-HUA LIU ; Liang, Cheng-Chao; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Lin, Chih-Lin; Yang, Sheng-Shun; TUNG-HUNG SU ; JOU-WEI LIN ; Chen, Jun-Herng; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral therapy | 21 | 22 | |
152 | 2012 | Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters | TAI-CHUNG TSENG ; CHUN-JEN LIU ; CHI-LING CHEN ; Wang C.-C.; TUNG-HUNG SU ; Kuo S.F.-T.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 47 | 44 | |
153 | 2012 | Host genetic variants and hepatitis b virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission | Lin C.-L.; TAI-CHUNG TSENG ; TUNG-HUNG SU ; CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology International | 1 | 1 | |
154 | 2012 | Young chronic hepatitis b patients with nucleos(t)ide analogue-induced hepatitis b e antigen seroconversion have a higher risk of HBV reactivation | TAI-CHUNG TSENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; Wang C.-C; CHI-LING CHEN ; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 44 | 43 | |
155 | 2012 | Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy | WANG-HUEI SHENG ; CHIEN-CHING HUNG ; SUI-YUAN CHANG ; CHUN-JEN LIU ; Chen M.-Y.; SZU-MIN HSIEH ; JIA-HORNG KAO ; PEI-JER CHEN ; SHAN-CHWEN CHANG | Clinical Infectious Diseases | 13 | 12 | |
156 | 2012 | Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese | CHUN-JEN LIU | Journal of Gastroenterology and Hepatology (Australia) | 170 | 153 | |
157 | 2012 | Influences of tobacco and alcohol use on hepatocellular carcinoma survival | WEI-LIANG SHIH ; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN ; CHUN-JEN LIU ; Lin C.-L.; MING-WHEI YU | International Journal of Cancer | 49 | 44 | |
158 | 2012 | Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinoma | JIA-HORNG KAO ; CHUN-JEN LIU ; Jow G.-M.; PEI-JER CHEN ; DING-SHINN CHEN ; Chen B.-F. | Liver International | 33 | 30 | |
159 | 2012 | Advances in the treatment of chronic hepatitis C: From interferon to direct acting anti-virals | CHUN-JEN LIU ; Hsu C.-S.; JIA-HORNG KAO | Journal of Internal Medicine of Taiwan | 1 | ||
160 | 2012 | Erratum: Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update (Hepatology International (2012) 6 (531-561) DOI: 10.1007/s12072-012-9365-4) | Liaw Y.-F.; JIA-HORNG KAO ; Piratvisuth T.; Chan H.L.Y.; Chien R.-N.; CHUN-JEN LIU ; Gane E.; Locarnini S.; Lim S.-G.; Han K.-H.; Amarapurkar D.; Cooksley G.; Jafri W.; Mohamed R.; Hou J.-L.; Chuang W.-L.; Lesmana L.A.; Sollano J.D.; Suh D.-J.; Omata M. | Hepatology International | 16 | 18 | |
161 | 2011 | Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients | CHEN-HUA LIU ; Liang, Cheng-Chao; KAI-WEN HUANG ; CHUN-JEN LIU ; Chen, Shih-I; JOU-WEI LIN ; Hung, Peir-Haur; Tsai, Hung-Bin; Lai, Ming-Yang; PEI-JER CHEN ; Chen, Jun-Herng; DING-SHINN CHEN ; JIA-HORNG KAO | Clinical journal of the American Society of Nephrology : CJASN | 71 | 69 | |
162 | 2011 | The clinical significance of occult hepatitis B transfusion in Taiwan - a look-back study | TUNG-HUNG SU ; PEI-JER CHEN ; Chen T.-C.; Cheng H.-R.; Li L.; Lin K.-S.; JIA-HORNG KAO ; DING-SHINN CHEN ; CHUN-JEN LIU | Transfusion Medicine | 30 | 26 | |
163 | 2011 | Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: Genotype B vs C | CHUN-JEN LIU ; Cheng H.-R.; Chen C.-L.; Chen T.-C.; TAI-CHUNG TSENG ; Wang Z.-L.; PEI-JER CHEN ; CHEN-HUA LIU ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Viral Hepatitis | 20 | 19 | |
164 | 2011 | Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy | TAI-CHUNG TSENG ; Yu M.-L.; CHUN-JEN LIU ; Lin C.-L.; Huang Y.-W.; Hsu C.-S.; CHEN-HUA LIU ; Kuo S.F.-T.; Pan C.J.-H.; Yang S.-S.; Su C.-W.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 76 | 70 | |
165 | 2011 | HCV core gene polymorphisms correlate with liver fibrosis but not sustained virological response in patients with genotype 1 infection | SHIH-JER HSU ; Hsu C.-S.; CHEN-HUA LIU ; CHUN-JEN LIU ; CHI-LING CHEN ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 6 | 5 | |
166 | 2011 | Community and personal risk factors for hepatitis C virus infection: A survey of 23 820 residents in Taiwan in 1991-2 | Lee M.-H.; Yang H.-I.; Jen C.-L.; Lu S.-N.; Shiou-Hwei Yeh ; CHUN-JEN LIU ; You S.-L.; Sun C.-A.; Wang L.-Y.; WEI J. CHEN ; Chen C.-J.; R.E.V.E.A.L.-HCV Study Group; (CHYI-FENG JAN) | Gut | 49 | 50 | |
167 | 2011 | Hepatitis B viraemia: Its heritability and association with common genetic variation in the interferon γ signalling pathway | Huang H.-H.; WEI-LIANG SHIH ; Li Y.-H.; Wu C.-F.; PEI-JER CHEN ; Lin C.-L.; CHUN-JEN LIU ; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; MING-WHEI YU | Gut | 23 | 23 | |
168 | 2011 | Serum p53 gene polymorphisms and severity of hepatitis B or C-related chronic liver diseases in Taiwan | Mah Y.-H.; Hsu C.-S.; CHEN-HUA LIU ; CHUN-JEN LIU ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology International | 12 | 10 | |
169 | 2011 | Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy | Hsu C.-S.; SHIH-JER HSU ; Chen H.-C.; TAI-CHUNG TSENG ; CHEN-HUA LIU ; Niu W.-F.; Jeng J.; CHUN-JEN LIU ; Lai M.-Y.; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | Proceedings of the National Academy of Sciences of the United States of America | 56 | 54 | |
170 | 2011 | Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: Results from 17-year follow-up of a population-based cohort | Chao L.-T.; Wu C.-F.; Sung F.-Y.; Lin C.-L.; CHUN-JEN LIU ; Huang C.-J.; KEH-SUNG TSAI ; MING-WHEI YU | Carcinogenesis | 52 | 45 | |
171 | 2011 | Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters | TAI-CHUNG TSENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; Wang C.; CHI-LING CHEN ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Gastroenterology | 180 | 167 | |
172 | 2011 | Functional impairment of dendritic cells in patients infected with hepatitis C virus genotype 1 who failed peginterferon plus ribavirin therapy | Liang C.-C.; CHEN-HUA LIU ; Lin Y.-L.; CHUN-JEN LIU ; BOR-LUEN CHIANG ; JIA-HORNG KAO | Journal of Medical Virology | 10 | 7 | |
173 | 2011 | Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses | Yeh M.-L.; Hung C.-H.; Huang J.-F.; CHUN-JEN LIU ; Lee C.-M.; Dai C.-Y.; Wang J.-H.; Lin Z.-Y.; Lu S.-N.; Hu T.-H.; Yu M.-L.; JIA-HORNG KAO ; Chuang W.-L.; PEI-JER CHEN ; DING-SHINN CHEN | PLoS ONE | 19 | 15 | |
174 | 2010 | Metabolic syndrome on top of chronic hepatitis B: the more, the worse? | LI-CHUN CHANG ; Chung, Chen-Shuan; CHUN-JEN LIU ; JIA-HORNG KAO | Gut | 1 | 1 | |
175 | 2010 | Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B | TUNG-HUNG SU ; Hsu C.-S.; CHI-LING CHEN ; CHEN-HUA LIU ; Huang Y.-W.; TAI-CHUNG TSENG ; CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 78 | 73 | |
176 | 2010 | Implications of hepatitis B virus genomic variations on treatment outcomes | TAI-CHUNG TSENG ; CHUN-JEN LIU ; JIA-HORNG KAO | Current Pharmacogenomics and Personalized Medicine | 5 | 0 | |
177 | 2010 | Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B | Huang Y.-W.; Chayama K.; Tsuge M.; Takahashi S.; Hatakeyama T.; Abe H.; Hu J.-T.; CHUN-JEN LIU ; Lai M.-Y.; DING-SHINN CHEN ; Yang S.-S.; JIA-HORNG KAO | Antiviral Therapy | 39 | 38 | |
178 | 2010 | The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C | CHEN-HUA LIU ; Liang C.-C.; CHUN-JEN LIU ; SHIH-JER HSU ; JOU-WEI LIN ; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; PEI-JER CHEN ; Chen J.-H.; DING-SHINN CHEN ; JIA-HORNG KAO | Kidney International | 31 | 32 | |
179 | 2010 | Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection | Hsu C.-S.; Wang C.-C.; Wang P.-C.; Lin H.H.; TAI-CHUNG TSENG ; Chen C.-H.; Su W.-C.; CHUN-JEN LIU ; CHI-LING CHEN ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology International | 14 | 16 | |
180 | 2010 | Hepatitis C virus infection and increased risk of cerebrovascular disease | Lee M.-H.; Yang H.-I.; Wang C.-H.; Jen C.-L.; Shiou-Hwei Yeh ; CHUN-JEN LIU ; You S.-L.; WEI J. CHEN ; Chen C.-J. | Stroke | 127 | 121 | |
181 | 2010 | Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan | Huang Y.-W.; Liao Y.-T.; Chen W.; CHI-LING CHEN ; Hu J.-T.; CHUN-JEN LIU ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; Yang S.-S.; JIA-HORNG KAO | Genes and Immunity | 45 | 38 | |
182 | 2010 | Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: Long-term predictors from a community-based cohort study | Lee M.-H.; Yang H.-I.; Lu S.-N.; Jen C.-L.; Shiou-Hwei Yeh ; CHUN-JEN LIU ; PEI-JER CHEN ; You S.-L.; Wang L.-Y.; WEI J. CHEN ; Chen C.-J. | Journal of Clinical Oncology | 143 | 131 | |
183 | 2010 | HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses | Yu M.-L.; Lee C.-M.; Chuang W.-L.; Lu S.-N.; Dai C.-Y.; Huang J.-F.; Lin Z.-Y.; Hu T.-I.; Chen C.-H.; Hung C.-.; Wang J.-H.; CHI-LING CHEN ; JIA-HORNG KAO ; Lai M.-Y.; CHEN-HUA LIU ; TUNG-HUNG SU ; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; PEI-JER CHEN ; CHUN-JEN LIU ; DING-SHINN CHEN | Journal of Infectious Diseases | 42 | 37 | |
184 | 2010 | Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C | CHEN-HUA LIU ; Liang C.-C.; CHUN-JEN LIU ; JOU-WEI LIN ; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Clinical Infectious Diseases | 30 | 26 | |
185 | 2010 | Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection | Hsu C.-S.; CHEN-HUA LIU ; CHUN-JEN LIU ; SHIH-JER HSU ; CHI-LING CHEN ; HWANG, JUEY-JEN ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 30 | 30 | |
186 | 2009 | Dual chronic hepatitis B virus and hepatitis C virus infection | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN | Hepatology International | 43 | 37 | |
187 | 2009 | Patterns of managing chronic hepatitis B treatment-related drug resistance: A survey of physicians in Mainland China, South Korea, Taiwan, and Thailand | Chainuvati S.; Cheng J.; Hou J.L.; Hsu C.W.; Jia J.D.; Komolmit P.; Kwon S.Y.; Lee C.H.; Li H.; Li Y.; CHUN-JEN LIU ; Neo B.L.; Peng C.Y.; Tanwandee T.; Wongcharatrawee S.; Wu J.C.; Yu M.L.; Zhang X.X. | Hepatology International | 9 | 8 | |
188 | 2009 | Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses | CHUN-JEN LIU ; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; CHI-LING CHEN ; Kuo H.; Chao Y.; Tung S.; Yang S.; JIA-HORNG KAO ; CHEN-HUA LIU ; Su W.; Lin C.; YUNG-MING JENG ; PEI-JER CHEN ; DING-SHINN CHEN | Gastroenterology | 182 | 157 | |
189 | 2009 | Characterization of interleukin 8 in woodchucks with chronic hepatitis B and hepatocellular carcinoma | CHUN-JEN LIU ; Huang Y.-J.; HUEY-LING CHEN ; Lin H.-T.; Lin H.-L.; Kuo M.-L.; Huang J.-L.; DING-SHINN CHEN ; PEI-JER CHEN ; Wu H.-L. | Genes and Immunity | 4 | 5 | |
190 | 2009 | Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection | Hsu C.-S.; CHEN-HUA LIU ; CHUN-JEN LIU ; Wang C.-C.; CHI-LING CHEN ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | American Journal of Gastroenterology | 37 | 34 | |
191 | 2009 | Human leukocyte antigen-DRB1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virus | Huang Y.-W.; CHUNG-YI HU ; CHI-LING CHEN ; Liao Y.-T.; CHUN-JEN LIU ; Lai M.-Y.; PEI-JER CHEN ; Yang S.-S.; Hu J.-T.; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Medical Virology | 7 | 6 | |
192 | 2009 | Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage | CHUN-JEN LIU ; PO-HUANG LEE ; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin P.-W.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; MING-CHIH HO ; Yang S.-S.; Lee C.-C.; Yu M.-C.; REY-HENG HU ; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; PEI-JER CHEN | Journal of Hepatology | 131 | 125 | |
193 | 2009 | Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels | TAI-CHUNG TSENG ; CHUN-JEN LIU ; Wang C.-C.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 16 | 12 | |
194 | 2009 | High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection | CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; CHEN-HUA LIU ; CHI-LING CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | Hepatology International | 32 | 29 | |
195 | 2009 | Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy | CHEN-HUA LIU ; Liang C.-C.; CHUN-JEN LIU ; Tsai H.-B.; Hung P.-H.; SHIH-JER HSU ; Chen S.-L.; JOU-WEI LIN ; Lai M.-Y.; Chen J.-H.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Gut | 26 | 23 | |
196 | 2009 | Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy | TAI-CHUNG TSENG ; CHUN-JEN LIU ; SONG-CHOU HSIEH ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Digestive and Liver Disease | 3 | 3 | |
197 | 2009 | Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C | Hsieh T.-H.; TAI-CHUNG TSENG ; CHUN-JEN LIU ; Lai M.-Y.; PEI-JER CHEN ; Hsieh H.-L.; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 30 | 24 | |
198 | 2009 | Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy | Hsu C.-S.; CHEN-HUA LIU ; CHUN-JEN LIU ; CHI-LING CHEN ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 33 | 30 | |
199 | 2009 | Evidence for association with hepatocellular carcinoma at the PAPSS1 locus on chromosome 4q25 in a family-based study | WEI-LIANG SHIH ; MING-WHEI YU ; PEI-JER CHEN ; Wu T.-W.; Lin C.-L.; CHUN-JEN LIU ; Lin S.-M.; Tai D.-I.; Lee S.-D.; Liaw Y.-F. | European Journal of Human Genetics | 19 | 17 | |
200 | 2009 | Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: A 20-year follow-up study | MEI-HWEI CHANG ; You S.-L.; Chen C.-J.; CHUN-JEN LIU ; Lee C.-M.; Lin S.-M.; Chu H.-C.; Wu T.-C.; Yang S.-S.; Kuo H.-S.; DING-SHINN CHEN | Journal of the National Cancer Institute | 494 | 408 | |
201 | 2009 | Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B | CHUN-JEN LIU ; YUNG-MING JENG ; CHI-LING CHEN ; Cheng H.-R.; PEI-JER CHEN ; Chen T.-C.; CHEN-HUA LIU ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 26 | 21 | |
202 | 2009 | Hepatitis B Virus Core Variants Modify Natural Course of Viral Infection and Hepatocellular Carcinoma Progression | Sung F.; Jung C.; Wu C.; Lin C.; CHUN-JEN LIU ; Liaw Y.; KEH-SUNG TSAI ; MING-WHEI YU | Gastroenterology | 35 | 34 | |
203 | 2008 | 先天性及專一性免疫在慢性B型肝炎病毒感染的角色-免疫病理機轉及治療上的意涵-急性肝炎和慢性B型肝炎急性發作中免疫反應的探討:著重於人體和土撥鼠動物模式中天生性免疫反應的角色(子計畫二)(3/3) | 劉俊人 | ||||
204 | 2008 | Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis | Wang C.-C.; Hsu C.-S.; CHUN-JEN LIU ; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 86 | 75 | |
205 | 2008 | Core promoter mutations of hepatitis B virus and hepatocellular carcinoma: Story beyond A1762T/G1764A mutations | CHUN-JEN LIU ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 5 | 5 | |
206 | 2008 | Acute fatty liver of pregnancy with concurrent acute hepatitis B virus infection | TUNG-HUNG SU ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | American Journal of Gastroenterology | 0 | 0 | |
207 | 2008 | Pegylated interferon-α-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trial | CHEN-HUA LIU ; CHUN-JEN LIU ; Lin C.-L.; Liang C.-C.; SHIH-JER HSU ; Yang S.-S.; Hsu C.-S.; TAI-CHUNG TSENG ; Wang C.-C.; Lai M.-Y.; Chen J.-H.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Clinical Infectious Diseases | 183 | 170 | |
208 | 2008 | Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection: A Follow-up Study in Taiwan | CHI-LING CHEN ; Yang HwaiI.; WEI-SHIUNG YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; You S.; Wang L.; Sun C.; Lu S.; DING-SHINN CHEN ; Chen C. | Gastroenterology | 470 | 426 | |
209 | 2008 | Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men | Wu C.-F.; MING-WHEI YU ; Lin C.-L.; CHUN-JEN LIU ; WEI-LIANG SHIH ; KEH-SUNG TSAI ; Chen C.-J. | Carcinogenesis | 75 | 73 | |
210 | 2008 | Hepatitis B virus quantification and detection of YMDD mutants in a single reaction by real-time PCR and annealing curve analysis | Shih Y.-H.; Shiou-Hwei Yeh ; PEI-JER CHEN ; Chou W.-P.; HURNG-YI WANG ; CHUN-JEN LIU ; Lu S.-F.; DING-SHINN CHEN | Antiviral Therapy | 9 | 5 | |
211 | 2008 | A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients | TAI-CHUNG TSENG ; CHUN-JEN LIU ; Wang C.-C.; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Liver International | 19 | 17 | |
212 | 2008 | The non-structural 5A protein of hepatitis C virus exhibits genotypic differences in interferon antagonism | Tsai Y.-H.; Kuang W.-F.; Lu T.-Y.; JIA-HORNG KAO ; Lai M.-Y.; CHUN-JEN LIU ; PEI-JER CHEN ; Hwang L.-H. | Journal of Hepatology | 17 | 17 | |
213 | 2008 | Pegylated interferon α-2a versus standard interferon α-2a for treatment-naïve dialysis patients with chronic hepatitis C: A randomised study | CHEN-HUA LIU ; Liang C.-C.; JOU-WEI LIN ; Chen S.-I.; Tsai H.-B.; Chang C.-S.; Hung P.-H.; JIA-HORNG KAO ; CHUN-JEN LIU ; Lai M.-Y.; Chen J.-H.; PEI-JER CHEN ; DING-SHINN CHEN | Gut | 67 | 61 | |
214 | 2008 | High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C | Hsu C.-S.; CHUN-JEN LIU ; CHEN-HUA LIU ; Wang C.-C.; CHI-LING CHEN ; Lai M.-Y.; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | Liver International | 95 | 91 | |
215 | 2008 | Genetic variability of hepatitis B virus and response to antiviral therapy | CHUN-JEN LIU ; JIA-HORNG KAO | Antiviral Therapy | 40 | 28 | |
216 | 2008 | Metabolic profiles in patients with chronic hepatitis C: A case-control study | Hsu C.-S.; CHUN-JEN LIU ; CHEN-HUA LIU ; CHI-LING CHEN ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology International | 27 | 28 | |
217 | 2008 | Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma | Chou Y.-C.; MING-WHEI YU ; Wu C.-F.; Yang S.-Y.; Lin C.-L.; CHUN-JEN LIU ; Shin W.-L.; PEI-JER CHEN ; Liaw Y.-F.; Chen C.-J. | Gut | 101 | 95 | |
218 | 2008 | Esophageal varices: Noninvasive diagnosis with duplex doppler US in patients with compensated cirrhosis | CHEN-HUA LIU ; SHIH-JER HSU ; Liang C.-C.; FENG-CHIAO TSAI ; JOU-WEI LIN ; CHUN-JEN LIU ; PEI-MING YANG ; Lai M.-Y.; PEI-JER CHEN ; Chen J.-H.; JIA-HORNG KAO ; DING-SHINN CHEN | Radiology | 27 | 24 | |
219 | 2008 | Disease progression in a patient with nonalcoholic steatohepatitis | PING-HUEI TSENG ; CHUN-JEN LIU ; JIA-HORNG KAO ; CHIA-TUNG SHUN ; PEI-JER CHEN ; DING-SHINN CHEN | Journal of the Formosan Medical Association | 10 | 6 | |
220 | 2008 | Viral hepatocarcinogenesis: From infection to cancer | Tan A.; Shiou-Hwei Yeh ; CHUN-JEN LIU ; Cheung C.; PEI-JER CHEN | Liver International | 102 | 84 | |
221 | 2008 | Body-mass index and progression of hepatitis B: A population-based cohort study in men | MING-WHEI YU ; WEI-LIANG SHIH ; Lin C.-L.; CHUN-JEN LIU ; Jian J.-W.; KEH-SUNG TSAI ; Chen C.-J. | Journal of Clinical Oncology | 104 | 100 | |
222 | 2007 | Noninvasive diagnosis of hepatic fibrosis in patients with chronic hepatitis C by splenic Doppler impedance index | CHEN-HUA LIU ; SHIH-JER HSU ; JOU-WEI LIN ; JUEY-JEN HWANG ; CHUN-JEN LIU ; PEI-MING YANG ; Lai, Ming-Yang; PEI-JER CHEN ; Chen, Jun-Herng; JIA-HORNG KAO ; DING-SHINN CHEN | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 27 | 22 | |
223 | 2007 | 先天性及專一性免疫在慢性B型肝炎病毒感染的角色-免疫病理機轉及治療上的意涵-急性肝炎和慢性B型肝炎急性發作中免疫反應的探討:著重於人體和土撥鼠動物模式中天生性免疫反應的角色(子計畫二)(2/3) | 劉俊人 | ||||
224 | 2007 | Reply [2] | Lin C.-L.; CHUN-JEN LIU ; JIA-HORNG KAO | Hepatology | 0 | 0 | |
225 | 2007 | Hepatitis B virus genotype: What should the clinician know? | CHUN-JEN LIU ; JIA-HORNG KAO | Current Hepatitis Reports | 6 | 0 | |
226 | 2007 | Lower serum viral loads in young patients with hepatitis-B-virus-related hepatocellular carcinoma | FENG-CHIAO TSAI ; CHUN-JEN LIU ; CHI-LING CHEN ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Viral Hepatitis | 17 | 17 | |
227 | 2007 | Sequential combination therapy for chronic hepatitis B: More challenges to be tackled [7] | TAI-CHUNG TSENG ; CHUN-JEN LIU ; JIA-HORNG KAO | American Journal of Gastroenterology | 1 | 1 | |
228 | 2007 | Interferon-based therapy for dialysis patients with chronic hepatitis C: Progress and challenges | CHEN-HUA LIU ; CHUN-JEN LIU ; JIA-HORNG KAO | Nephrology | 2 | 7 | |
229 | 2007 | Clinicopathological differences between hepatitis B viral genotype B- and C-related resectable hepatocellular carcinoma | Lin C.-L.; Chen J.-D.; CHUN-JEN LIU ; PO-HUANG LEE ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Viral Hepatitis | 23 | 21 | |
230 | 2007 | Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan | Hsu C.-S.; CHUN-JEN LIU ; Lai M.-Y.; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | Intervirology | 17 | 16 | |
231 | 2007 | Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients | Wang C.-C.; CHUN-JEN LIU ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Liver International | 7 | 7 | |
232 | 2007 | Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels | Lin C.-L.; Liao L.-Y.; CHUN-JEN LIU ; MING-WHEI YU ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 97 | 92 | |
233 | 2007 | Hepatitis B virus-related hepatocellular carcinoma: Epidemiology and pathogenic role of viral factors | CHUN-JEN LIU ; JIA-HORNG KAO | Journal of the Chinese Medical Association | 71 | 0 | |
234 | 2007 | Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan | TAI-CHUNG TSENG ; CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; Lin C.-L.; JIA-HORNG KAO ; DING-SHINN CHEN | Liver International | 15 | 15 | |
235 | 2007 | High prevalence of occult hepatitis B virus infection in Taiwanese intravenous drug users | Lin C.-L.; CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Medical Virology | 24 | 22 | |
236 | 2006 | Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan | CHUN-JEN LIU ; SHYH-CHYI LO ; JIA-HORNG KAO ; Tseng P.-T.; Lai M.-Y.; YEN-HSUAN NI ; Shiou-Hwei Yeh ; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Hepatology | 98 | 88 | |
237 | 2006 | Interferon α-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: A randomized study | CHUN-JEN LIU ; Lai M.-Y.; Chao Y.-C.; Liao L.-Y.; Yang S.-S.; Hsiao T.-J.; Hsieh T.-Y.; Lin C.-L.; Hu J.-T.; CHI-LING CHEN ; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | Hepatology | 41 | 35 | |
238 | 2006 | Reply [2] | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Hepatology | 0 | 0 | |
239 | 2006 | High Prevalence and Mapping of Pre-S Deletion in Hepatitis B Virus Carriers With Progressive Liver Diseases | Chen B.; CHUN-JEN LIU ; Jow G.; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | Gastroenterology | 247 | 232 | |
240 | 2006 | Viral factors correlate with hepatitis B e antigen seroconverson in patients with chronic hepatitis B | CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; Lin F.-Y.; Wang T.; JIA-HORNG KAO ; DING-SHINN CHEN | Liver International | 37 | 35 | |
241 | 2006 | Pegylated interferons for the treatment of chronic hepatitis B. | CHUN-JEN LIU ; JIA-HORNG KAO | Recent patents on anti-infective drug discovery | 5 | 0 | |
242 | 2006 | Evolution of hepatitis B virus in an acute hepatitis B patient co-infected with genotypes B and C | Chen B.-F.; CHUN-JEN LIU ; Jow G.-M.; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of General Virology | 32 | 28 | |
243 | 2006 | Reply [3] | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Hepatology | 0 | 0 | |
244 | 2006 | Epidemiology of HBV infection in Asian blood donors: Emphasis on occult HBV infection and the role of NAT | CHUN-JEN LIU ; DING-SHINN CHEN ; PEI-JER CHEN | Journal of Clinical Virology | 105 | 95 | |
245 | 2006 | Natural course and treatment of hepatitis D virus infection | Hsieh T.-H.; CHUN-JEN LIU ; DING-SHINN CHEN ; PEI-JER CHEN | Journal of the Formosan Medical Association | 44 | 39 | |
246 | 2006 | Hemobilia associated with acute calculus cholecystitis successfully treated with endoscopic naso-biliary drainage and laparoscopic cholecystectomy - A case report | Wang C.-C.; CHUN-JEN LIU ; Chen C.; Lin C.-H. | Tzu Chi Medical Journal | 1 | ||
247 | 2006 | Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series | Huang Y.-W.; CHUN-JEN LIU ; Lai M.-Y.; PO-HUANG LEE ; MENG-KUN TSAI ; SHOEI-SHEN WANG ; Lai M.-K.; JIA-HORNG KAO | Clinical Therapeutics | 7 | 6 | |
248 | 2006 | Kinetics of Hepatitis B Virus Reactivation After Chemotherapy: More Questions Than Answers | CHUN-JEN LIU ; JIA-HORNG KAO ; DING-SHINN CHEN | Gastroenterology | 7 | 7 | |
249 | 2006 | Clinical significance of occult hepatitis B virus infection cannot be overlooked [11] | CHUN-JEN LIU ; JIA-HORNG KAO ; DING-SHINN CHEN | Clinical Infectious Diseases | 1 | 1 | |
250 | 2006 | The Woodchuck Model for the Study of HBV-associated Hepatopathy-husbandry, Management and Laboratory Techniques | Lin, H.-L.; PEI-JER CHEN ; CHUN-JEN LIU ; JIA-HORNG KAO ; DING-SHINN CHEN ; Lee, P.-J.; Wu, H.-L. | Taiwan Veterinary Journal | |||
251 | 2006 | Erratum: "Natural course and treatment of dual hepatitis virus and hepatitis C virus infections" (Journal of Formosan Medical Association (2005) vol. 104 (11) (783-791)) | CHUN-JEN LIU ; JYH-MING LIOU ; DING-SHINN CHEN ; PEI-JER CHEN | Journal of the Formosan Medical Association | 0 | ||
252 | 2006 | Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic area | WEI-LIANG SHIH ; MING-WHEI YU ; PEI-JER CHEN ; Shiou-Hwei Yeh ; Lo M.-T.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; CHUN-JEN LIU ; Lee S.-D.; Lin C.-L.; CHUHSING KATE HSIAO ; Yang S.-Y.; Chen C.-J. | Oncogene | 17 | 14 | |
253 | 2006 | Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutants | CHUN-JEN LIU ; JIA-HORNG KAO ; PEI-JER CHEN ; Chen T.-C.; Lin F.-Y.; Lai M.-Y.; DING-SHINN CHEN | Journal of Viral Hepatitis | 14 | 12 | |
254 | 2006 | Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers | CHUN-JEN LIU ; Chen B.-F.; PEI-JER CHEN ; Lai M.-Y.; Huang W.-L.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Infectious Diseases | 161 | 142 | |
255 | 2006 | Mixed hepatitis B virus genotype infections: The more, the worse? [3] | CHUN-JEN LIU ; JIA-HORNG KAO ; DING-SHINN CHEN | Hepatology | 8 | 5 | |
256 | 2005 | Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C | CHUN-JEN LIU ; YUNG-MING JENG ; PEI-JER CHEN ; Lai M.-Y; HUNG-CHIH YANG ; Huang W.-L; JIA-HORNG KAO ; DING-SHINN CHEN | Antiviral Therapy | 34 | 32 | |
257 | 2005 | Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men | MING-WHEI YU ; Shiou-Hwei Yeh ; PEI-JER CHEN ; Liaw Y.-F.; Lin C.-L.; CHUN-JEN LIU ; WEI-LIANG SHIH ; JIA-HORNG KAO ; DING-SHINN CHEN ; Chen C.-J. | Journal of the National Cancer Institute | 495 | 426 | |
258 | 2005 | Successful treatment of acute hepatitis A-associated hemophagocytic syndrome by intravenous immunoglobulin | Tai C.-M.; CHUN-JEN LIU ; MING YAO | Journal of the Formosan Medical Association | 11 | 14 | |
259 | 2005 | Natural course and treatment of dual hepatitis B virus and hepatitis C virus infections | CHUN-JEN LIU ; JYH-MING LIOU ; DING-SHINN CHEN ; PEI-JER CHEN | Journal of the Formosan Medical Association | 45 | 36 | |
260 | 2005 | Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma | Chen C.-C.; Yang S.-Y.; CHUN-JEN LIU ; Lin C.-L.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN ; Chen C.-J.; MING-WHEI YU | International Journal of Epidemiology | 98 | 95 | |
261 | 2005 | Subgenotypes of hepatitis B virus genotype C in Taiwan [3] (multiple letters) | CHUN-JEN LIU ; JIA-HORNG KAO ; Chan H.L.-Y. | Journal of Infectious Diseases | 4 | 4 | |
262 | 2005 | Comparison of a 6-month course peginterferon α-2b plus ribavirin and interferon α-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan | Lee S.-D.; Yu M.-L.; Cheng P.-N.; Lai M.-Y.; Chao Y.-C.; Hwang S.-J.; Chang W.-Y.; Chang T.-T.; Hsieh T.-Y.; CHUN-JEN LIU ; DING-SHINN CHEN | Journal of Viral Hepatitis | 78 | 70 | |
263 | 2005 | Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C | CHUN-JEN LIU ; PEI-JER CHEN ; YUNG-MING JENG ; Huang W.-L.; WEI-SHIUNG YANG ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Hepatology | 67 | 59 | |
264 | 2005 | RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant | Wu H.-L.; Huang L.-R.; Huang C.-C.; Lai H.-L.; CHUN-JEN LIU ; Huang Y.-T.; Hsu Y.-W.; Lu C.-Y.; DING-SHINN CHEN ; PEI-JER CHEN | Gastroenterology | 96 | 93 | |
265 | 2005 | Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan | Mah Y.-H.; JIA-HORNG KAO ; CHUN-JEN LIU ; CHI-LING CHEN ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Liver International | 24 | 17 | |
266 | 2005 | Therapeutic implications of hepatitis B virus genotypes | CHUN-JEN LIU ; JIA-HORNG KAO ; DING-SHINN CHEN | Liver International | 108 | 82 | |
267 | 2004 | Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion | CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Medical Virology | 24 | 21 | |
268 | 2004 | End-of-treatment virologic response does not predict relapse after lamivudine treatment for chronic hepatitis B | CHUN-JEN LIU ; Huang W.-L.; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | World Journal of Gastroenterology | 14 | 12 | |
269 | 2004 | Genotypic Dominance and Novel Recombinations in HBV Genotype B and C Co-Infected Intravenous Drug Users | Chen B.-F.; JIA-HORNG KAO ; CHUN-JEN LIU ; DING-SHINN CHEN ; PEI-JER CHEN | Journal of Medical Virology | 44 | 38 | |
270 | 2004 | High prevalence of mixed genotype infections in hepatitis B virus infected intravenous drug users | Chen B.-F.; PEI-JER CHEN ; Jow G.-M.; Sablon E.; CHUN-JEN LIU ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Medical Virology | 42 | 36 | |
271 | 2004 | Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma | Chen J.-D.; CHUN-JEN LIU ; PO-HUANG LEE ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Clinical Gastroenterology and Hepatology | 45 | 44 | |
272 | 2004 | Lack of interferon sensitivity-determining region in the genome of hepatitis B virus genotype Ba | CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; Chen T.-C.; HURNG-YI WANG ; Huang W.-L.; JIA-HORNG KAO ; DING-SHINN CHEN | Antiviral Therapy | 9 | 8 | |
273 | 2004 | Origin of serum hepatitis B virus in acute exacerbation: Comparison with HBV in the liver and from other exacerbation | CHUN-JEN LIU ; JIA-HORNG KAO ; HURNG-YI WANG ; Lai M.-Y.; Chen T.-C.; PEI-JER CHEN ; DING-SHINN CHEN | Hepatology | 17 | 17 | |
274 | 2004 | A forgotten population with chronic hepatitis C infection: Subjects coinfected with hepatitis B virus [1] | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN | Hepatology | 14 | 12 | |
275 | 2004 | Precore/Core Promoter Mutations and Genotypes of Hepatitis B Virus in Chronic Hepatitis B Patients with Fulminant or Subfulminant Hepatitis | CHUN-JEN LIU ; JIA-HORNG KAO ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Medical Virology | 39 | 37 | |
276 | 2004 | Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis | Shiou-Hwei Yeh ; Tsai C.-Y.; JIA-HORNG KAO ; CHUN-JEN LIU ; Kuo T.-J.; Lin M.-W.; Huang W.-L.; Lu S.-F.; Jih J.; DING-SHINN CHEN ; PEI-JER CHEN | Journal of Hepatology | 193 | 182 | |
277 | 2003 | Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma | MING-WHEI YU ; Yang S.-Y.; Pan I.-J.; Lin C.-L.; CHUN-JEN LIU ; Liaw Y.-F.; Lin S.-M.; PEI-JER CHEN ; Lee S.-D.; Chen C.-J. | Journal of the National Cancer Institute | 107 | 95 | |
278 | 2003 | Molecular Assays for Hepatitis B Virus Infection [1] | CHUN-JEN LIU ; JIA-HORNG KAO ; DING-SHINN CHEN | Hepatology | 5 | 5 | |
279 | 2003 | Clinical aspects and outcomes of volunteer blood donors testing positive for hepatitis-C virus infection in Taiwan: A prospective study | CHUN-JEN LIU ; PEI-JER CHEN ; Shau W.-Y.; JIA-HORNG KAO ; Lai M.-Y.; DING-SHINN CHEN | Liver International | 24 | 22 | |
280 | 2003 | A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation | CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; Chang C.-F.; Wu H.-L.; Shau W.-Y.; DING-SHINN CHEN | Gastroenterology | 58 | 54 | |
281 | 2003 | Role of Reproductive Factors in Hepatocellular Carcinoma: Impact on Hepatitis B- and C-Related Risk | MING-WHEI YU ; Chang H.-C.; Chang S.-C.; Liaw Y.-F.; Lin S.-M.; CHUN-JEN LIU ; Lee S.-D.; Lin C.-L.; PEI-JER CHEN ; Lin S.-C.; Chen C.-J. | Hepatology | 159 | 127 | |
282 | 2003 | Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients | CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; YUNG-MING JENG ; DING-SHINN CHEN | Hepatology | 118 | 94 | |
283 | 2002 | Hepatitis B viral genotypes and lamivudine resistance [1] | JIA-HORNG KAO ; CHUN-JEN LIU ; DING-SHINN CHEN | Journal of Hepatology | 101 | 84 | |
284 | 2002 | Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in women | MING-WHEI YU ; Yang Y.-C.; Yang S.-Y.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; CHUN-JEN LIU ; Lee S.-D.; Lin C.-L.; PEI-JER CHEN ; Lin S.-C.; Chen C.-J. | Hepatology | 27 | 22 | |
285 | 2002 | Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot study | King J.K.; Shiou-Hwei Yeh ; Lin M.-W.; CHUN-JEN LIU ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN ; PEI-JER CHEN | Hepatology | 63 | 54 | |
286 | 2002 | Naturally occurring hepatitis B surface gene variants in chronic hepatitis B virus infection: Correlation with viral serotypes and clinical stages of liver disease | CHUN-JEN LIU ; JIA-HORNG KAO ; Shau W.-Y.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Medical Virology | 39 | 35 | |
287 | 2002 | Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B | Lin C.-L.; Liao L.-Y.; CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Gastroenterology | 37 | 37 | |
288 | 2002 | Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan | MING-WHEI YU ; Chang H.-C.; PEI-JER CHEN ; CHUN-JEN LIU ; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Lin S.-C.; Lin C.-L.; Chen C.-J. | International Journal of Epidemiology | 27 | 27 | |
289 | 2002 | Molecular epidemiology of hepatitis B viral serotypes and genotypes in Taiwan | CHUN-JEN LIU ; JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.Y.; DING-SHINN CHEN | Journal of Biomedical Science | 40 | 37 | |
290 | 2001 | Risk factors for ICU mortality in critically ill patients | YEE-CHUN CHEN ; Lin S.-F.; CHUN-JEN LIU ; Jiang D.D.-S.; PAN-CHYR YANG ; SHAN-CHWEN CHANG | Journal of the Formosan Medical Association | 42 | 42 | |
291 | 2001 | Amebic liver abscess and human immunodeficiency virus infection: A report of three cases | CHUN-JEN LIU ; CHIEN-CHING HUNG ; Chen M.-Y.; YO-PING LAI ; PEI-JER CHEN ; Huang S.-H.; DING-SHINN CHEN | Journal of Clinical Gastroenterology | 31 | 20 | |
292 | 2001 | Hepatitis B virus variants in patients receiving lamivudine treatment with breakthrough hepatitis evaluated by serial viral loads and full-length viral sequences | CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Hepatology | 46 | 46 | |
293 | 2001 | Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: A 4-year experience | CHUN-JEN LIU ; Lai M.-Y.; PO-HUANG LEE ; NAI-KUAN CHOU ; Chu S.-H.; PEI-JER CHEN ; JIA-HORNG KAO ; Jen Y.-M.; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 36 | 32 | |
294 | 2001 | Molecular cloning and expression of woodchuck granulocyte-macrophage colony stimulating factor | Wu H.-L.; PEI-JER CHEN ; Lin H.-K.; Lee R.-S.; Lin H.-L.; CHUN-JEN LIU ; Lee P.-J.; Lee J.J.; DING-SHINN CHEN | Journal of Medical Virology | 8 | 9 | |
295 | 2000 | Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma | MING-WHEI YU ; Cheng S.-W.; Lin M.-W.; Yang S.-Y.; Liaw Y.-F.; Chang H.-C.; Hsiao T.-J.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN ; CHUN-JEN LIU ; Chen C.-J. | JNCI Journal of the National Cancer Institute | 132 | 117 | |
296 | 2000 | Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives | MING-WHEI YU ; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; CHUN-JEN LIU ; PEI-JER CHEN ; Hsiao T.-J.; PO-HUANG LEE ; Chen C.-J. | Journal of the National Cancer Institute | 210 | 183 | |
297 | 2000 | Low incidence of hepatitis C virus transmission between spouses: A prospective study | JIA-HORNG KAO ; CHUN-JEN LIU ; PEI-JER CHEN ; Chen W.; Lai M.-Y.; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 52 | 37 | |
298 | 2000 | Interspousal transmission of TT virus: Low efficiency and lack of apparent risk factors | CHUN-JEN LIU ; JIA-HORNG KAO ; Chen W.; Tsai R.-J.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 2 | 2 |